Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium
Abstract Fibrous Dysplasia/McCune Albright syndrome (FD/MAS) represents a wide
spectrum of diseases due to somatic gain-of-function mutations of the GNAS gene. The …
spectrum of diseases due to somatic gain-of-function mutations of the GNAS gene. The …
[HTML][HTML] Guidelines for validation of next-generation sequencing–based oncology panels: a joint consensus recommendation of the Association for Molecular …
LJ Jennings, ME Arcila, C Corless… - The Journal of molecular …, 2017 - Elsevier
Next-generation sequencing (NGS) methods for cancer testing have been rapidly adopted
by clinical laboratories. To establish analytical validation best practice guidelines for NGS …
by clinical laboratories. To establish analytical validation best practice guidelines for NGS …
[HTML][HTML] Fibrous dysplasia/mccune-albright syndrome
Fibrous dysplasia/McCune-Albright syndrome (FD/MAS), the result of an early embryonic
postzygotic somatic activating pathogenic variant in GNAS (encoding the cAMP pathway …
postzygotic somatic activating pathogenic variant in GNAS (encoding the cAMP pathway …
Fibrous dysplasia of bone: craniofacial and dental implications
Fibrous dysplasia (FD) is a rare bone disease caused by postzygotic somatic activating
mutations in the GNAS gene, which lead to constitutive activation of adenylyl cyclase and …
mutations in the GNAS gene, which lead to constitutive activation of adenylyl cyclase and …
The clinical spectrum of McCune-Albright syndrome and its management
T Spencer, KS Pan, MT Collins… - Hormone research in …, 2020 - karger.com
McCune-Albright syndrome (MAS) is a rare, mosaic disorder presenting along a broad
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …
Endothelin-1 pathway polymorphisms and outcomes in pulmonary arterial hypertension
RL Benza, M Gomberg-Maitland… - American journal of …, 2015 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is a progressive fatal disease. Variable
response and tolerability to PAH therapeutics suggests that genetic differences may …
response and tolerability to PAH therapeutics suggests that genetic differences may …
Identification of GNAS Variants in Circulating Cell‐Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome
KL Roszko, L Guthrie, X Li, MT Collins… - Journal of Bone and …, 2023 - academic.oup.com
ABSTRACT Fibrous dysplasia/McCune‐Albright syndrome (FD/MAS) is a rare mosaic bone
and endocrine disorder. Although most variants affect the GNAS R201 codon, obtaining a …
and endocrine disorder. Although most variants affect the GNAS R201 codon, obtaining a …
Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects
S Pepe, M Korbonits, D Iacovazzo - Journal of Endocrinology, 2019 - joe.bioscientifica.com
While 95% of pituitary adenomas arise sporadically without a known inheritable
predisposing mutation, in about 5% of the cases they can arise in a familial setting, either …
predisposing mutation, in about 5% of the cases they can arise in a familial setting, either …
Genetic and functional analyses of TBX4 reveal novel mechanisms underlying pulmonary arterial hypertension
Y Yoshida, K Uchida, K Kodo, H Shibata… - Journal of Molecular and …, 2022 - Elsevier
Background Pulmonary arterial hypertension (PAH) is a fatal disease, with approximately
10% of cases associated with genetic variants. Recent genetic studies have reported …
10% of cases associated with genetic variants. Recent genetic studies have reported …
Sexual precocity-genetic bases of central precocious puberty and autonomous gonadal activation
Precocious puberty has been classically defined as the onset of sexual secondary
characteristics in girls younger than 8 years and in boys younger than 9 years. The …
characteristics in girls younger than 8 years and in boys younger than 9 years. The …